Rezaie, P., Bitarafan, V., Horowitz, M., & Feinle-Bisset, C
Liraglutide was also associated with a reduction in mean ALT levels, which, however, disappeared after correction for changes in weight and HbA 1c (62, 63)
Personalized care models can address these gaps with regular check-ins, side effect education, and real-time support that help GLP-1 users stay informed and on track
For patients who are deconditioned, even a modest, progressively graduated walking program can initiate the activation of this adaptive response
In its 348th meeting, the Registration Board decided that the Mecobalamin / Methylcobalamin Tablet monograph will now follow the Japanese Pharmacopoeia (JP) standards
The most successful strategy for maintaining GLP-1 results involves building the behavioral foundation during treatment